Familial adenomatosis polyposis–related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
暂无分享,去创建一个
Robin L. Jones | A. D. Dei Tos | P. Hohenberger | A. Gronchi | J. Martín-Broto | S. Stacchiotti | B. Vincenzi | M. Silletta | G. Tonini | D. Santini | M. Nannini | S. Gasperoni | A. Napolitano | A. Brunello | T. Ibrahim | M. Vitellaro | N. Hindi | E. Palassini | G. Badalamenti | S. Gennatas | S. Provenzano | C. Colombo | M. Spalato Ceruso
[1] J. Blay,et al. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. , 2019, The Lancet. Oncology.
[2] Narasimhan P. Agaram,et al. Sorafenib for Advanced and Refractory Desmoid Tumors , 2018, The New England journal of medicine.
[3] Maria Laura DE Marchis,et al. Desmoid Tumors in Familial Adenomatous Polyposis. , 2017, Anticancer research.
[4] J. Blay,et al. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG) , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] G. Rauch,et al. Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). , 2017, European journal of cancer.
[6] P. Meltzer,et al. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] L. Mariani,et al. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis , 2017, Cancer journal.
[8] Jong Hoon Park,et al. Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis. , 2016, Japanese journal of clinical oncology.
[9] A. Rosenberg,et al. Desmoid fibromatosis: MRI features of response to systemic therapy , 2016, Skeletal Radiology.
[10] Hongying Dai,et al. Desmoid tumors complicating Familial Adenomatous Polyposis: a meta-analysis mutation spectrum of affected individuals , 2015, BMC Gastroenterology.
[11] Y. Ando,et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status , 2015, International Journal of Clinical Oncology.
[12] I. Cecconello,et al. Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis , 2014, Familial Cancer.
[13] P. Radice,et al. Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis , 2014, The British journal of surgery.
[14] S. Bonvalot,et al. Spontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously Thought , 2013, Annals of Surgical Oncology.
[15] Ko-Wei Lih,et al. Equivalence of two conjectures on equitable coloring of graphs , 2013, J. Comb. Optim..
[16] C. Fletcher,et al. WHO classification of tumours of soft tissue and bone , 2013 .
[17] H. Järvinen,et al. Family History, Surgery, and APC Mutation Are Risk Factors for Desmoid Tumors in Familial Adenomatous Polyposis: An International Cohort Study , 2011, Diseases of the colon and rectum.
[18] M. Isler,et al. Low-dose chemotherapy for extra-abdominal desmoid tumor. , 2008, Saudi medical journal.
[19] S. Skapek,et al. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] H. Ikeuchi,et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] E. Tiret,et al. Long-term Outcome of Familial Adenomatous Polyposis Patients After Restorative Coloproctectomy , 2004, Annals of surgery.
[22] P. Casali,et al. Low‐dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis , 2001, Cancer.
[23] J. Gebert,et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families , 2001, Gut.
[24] A. Weiss,et al. Therapy of desmoid tumors and fibromatosis using vinorelbine. , 1999, American journal of clinical oncology.
[25] A. Weiss,et al. Low‐dose chemotherapy of desmoid tumors , 1989, Cancer.